Strong Expression of SLAMF7 in Natural Killer/T-cell Lymphoma and Large Granular Lymphocyte Leukemia - a Prominent Biomarker and Potential Target for Anti-SLAMF7 Antibody Therapy
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Natural Killer Cell-Mediated Immunotherapy for Leukemia.
Allison M, Mathews J, Gilliland T, Mathew S Cancers (Basel). 2022; 14(3).
PMID: 35159109 PMC: 8833963. DOI: 10.3390/cancers14030843.
Recent updates on CAR T clinical trials for multiple myeloma.
Lin Q, Zhao J, Song Y, Liu D Mol Cancer. 2019; 18(1):154.
PMID: 31684964 PMC: 6829852. DOI: 10.1186/s12943-019-1092-1.